Percheron Therapeutics Ltd (PER) — Cash Flow Quality Index

Latest as of June 2025: -0.84x

Percheron Therapeutics Ltd (PER) has a Cash Flow Quality Index of -0.84x as of June 2025. Operating cash flow of AU$-7.16 Million is below net income of AU$8.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Percheron Therapeutics Ltd (PER) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-0.84x
Operating CF / Net Income

Operating Cash Flow

AU$-7.16 Million
AUD

Net Income

AU$8.54 Million
AUD

Data as of

Jun 2025
Most recent filing

Percheron Therapeutics Ltd Cash Flow Quality Index (2015–2015)

Historical Cash Flow Quality Index for Percheron Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see PER cash flow metrics.

Annual Cash Flow Quality Index for Percheron Therapeutics Ltd (2015–2015)

Year-by-year earnings quality comparison for Percheron Therapeutics Ltd.

Year Quality Index Operating CF (AUD) Net Income YoY Change
2015 1.79x AU$1.27 Million AU$706.92K —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.